Navigation Links
Amicus Therapeutics Announces Second Quarter 2009 Financial Results Release Date
Date:7/29/2009

CRANBURY, N.J., July 29 /PRNewswire-FirstCall/ -- Amicus Therapeutics (Nasdaq: FOLD) will announce second quarter 2009 financial results after the regular close of markets on Wednesday, August 5, 2009. The results announcement will be followed by a live conference call and webcast that afternoon at 5 p.m. EDT.

Interested participants and investors may access the conference call at 5 p.m. EDT by dialing 877-591-4949 (U.S./Canada) or 719-325-4889 (international). A telephonic replay of the call will be available for seven days beginning at 8 p.m. EDT. Access numbers for this replay are 888-203-1112 (U.S./Canada) and 719-457-0820 (international); participant code 4035217.

An audio webcast can also be accessed via the investor section of the Amicus Therapeutics Web site at www.amicustherapeutics.com under Investors: Events and Presentations. Web participants are encouraged to go to the Web site 15 minutes prior to the start of the call to register, download and install any necessary software. After the live webcast, an audio webcast replay will remain available in the Investors section of the Amicus Therapeutics Web site for 30 days.

Amicus' press releases are available at www.amicustherapeutics.com.

About Amicus Therapeutics

Amicus Therapeutics is a biopharmaceutical company developing novel, oral therapeutics known as pharmacological chaperones for the treatment of a range of human genetic diseases. Pharmacological chaperone technology involves the use of small molecules that selectively bind to and stabilize proteins in cells, leading to improved protein folding and trafficking, and increased activity.
'/>"/>

SOURCE Amicus Therapeutics
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Amicus Therapeutics to Present at the Bank of America and Merrill Lynch 2009 Health Care Conference on May 13, 2009
2. Amicus Therapeutics Announces First Quarter 2009 Financial Results Release Date
3. Amicus Therapeutics to Present at the 16th Annual Future Leaders in the Biotech Industry Conference
4. Amicus Therapeutics Presents Positive Results From Phase 2 Extension Study of Amigal(TM) for Fabry Disease at ACMG 2009 Annual Meeting
5. Amicus Therapeutics to Present at the Cowen and Company 29th Annual Healthcare Conference on March 17, 2009
6. Amicus Therapeutics Announces Change to Board of Directors
7. Amicus Therapeutics Announces Fourth Quarter and Full Year 2008 Financial Results
8. Amicus Therapeutics Announces Fourth Quarter and Year End 2008 Financial Results Release Date
9. Amicus Therapeutics Adds Sol J. Barer, Ph.D. to Board of Directors
10. Amicus Therapeutics to Present at Lazard Capital Markets Healthcare Conference
11. Amicus Therapeutics Announces Third Quarter 2008 Financial Results

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)... PDS, a leader in providin...community, announces Pajama Pathology®, evolut...g the same ‘gold standard’ software us...the world, but on a ‘cost per slide’ b...NJ (PRWEB) November 30, 2009 -- PDS has announced ...
(Date:11/30/2009)..., , BOSTON and COPENHAGEN, Nov. 30 /PRNew...) announced today that the Harvard Medical School ... recognized as a MicroRNA Screening Center of Exce...Medical School, and associated hospitals and insti...lecule and RNAi libraries. ,, MicroRNAs are a n...
(Date:11/30/2009)..., , LONDON, November 30 /PRNew...ics company, was named Europe,s fastest growing,Bi...company in the Deloitte,2009 Technology Fast 500 f... This annual ranking is based on a companies, fi...eved a rate of 8,318% over this period. This,achie...
(Date:11/29/2009)... This release is available in German . , T...eas in modern physics. The most famous example is ... and neutrons. Now Prof. Bella Lake from Helmholtz...m of scientists report for the first time an exper...nomenon observed in a condensed matter system. , ...
Breaking Biology Technology:Pajama Pathology -- the New Wave of Preclinical Pathology Embraced by PDS 2Pajama Pathology -- the New Wave of Preclinical Pathology Embraced by PDS 3Exiqon Recognizes Harvard Medical School Core Facility as MicroRNA Screening Center of Excellence 2Exiqon Recognizes Harvard Medical School Core Facility as MicroRNA Screening Center of Excellence 3ApaTech is Europe's Fastest Growing Lifescience Company 2ApaTech is Europe's Fastest Growing Lifescience Company 3ApaTech is Europe's Fastest Growing Lifescience Company 4Spinons -- confined like quarks 2
...her gDNA Concentrations with the Perfect gDNA Bloo...n Volume , , , , , , , ...Eppendorf 5 Prime, Boulder, Colorado, , ,...he Eppendorf Perfect gDNA Blood Mini Kit protoco... for maximum total yield in standard , ap...
..., , , , , , , Laura Po... , Eppendorf 5 Prime, Inc., , , ...fect gDNA Blood Mini Kit is an efficient way to pu...ood as described in the product manual. , ...lso be used to effectively , purify genom...
..., , , , , , , , ...roduction of , single-stranded DNA may be i... Propagate M13 phage by one of the standar...oducing M13 ssDNA, mix 2.5 ml plating bacteria (57...4 C for no more than 3 days) , with...
Other Biology Technology:Higher gDNA Concentrations with the Perfect gDNA Blood Mini Kit , by Varying the Final Elution Volume 2Higher gDNA Concentrations with the Perfect gDNA Blood Mini Kit , by Varying the Final Elution Volume 3Higher gDNA Concentrations with the Perfect gDNA Blood Mini Kit , by Varying the Final Elution Volume 4Higher gDNA Concentrations with the Perfect gDNA Blood Mini Kit , by Varying the Final Elution Volume 5Higher gDNA Concentrations with the Perfect gDNA Blood Mini Kit , by Varying the Final Elution Volume 6Higher gDNA Concentrations with the Perfect gDNA Blood Mini Kit , by Varying the Final Elution Volume 7Genomic DNA Extraction from Buffy Coat Using the Perfect gDNA Blood , Mini Kit 2Genomic DNA Extraction from Buffy Coat Using the Perfect gDNA Blood , Mini Kit 3Genomic DNA Extraction from Buffy Coat Using the Perfect gDNA Blood , Mini Kit 4Genomic DNA Extraction from Buffy Coat Using the Perfect gDNA Blood , Mini Kit 5Genomic DNA Extraction from Buffy Coat Using the Perfect gDNA Blood , Mini Kit 6Genomic DNA Extraction from Buffy Coat Using the Perfect gDNA Blood , Mini Kit 7Genomic DNA Extraction from Buffy Coat Using the Perfect gDNA Blood , Mini Kit 8M13/Phagemid DNA Extraction Protocol 2
(Date:11/30/2009)... , VILNIUS, Lithuania, Nov. 30 /PRNew...logy.com ), a provider of high-precision biometric... upgrades in the company,s core product line: Ver...al recognition and MegaMatcher 3.1 SDK for large...dentification systems (AFIS). Expanded capabilitie...
(Date:11/26/2009)...rized for their impressive antlers, red deer have .... But a deer,s antlers are much more than decorati...her when duelling. John Currey, from The Universit...l properties of bone for over half a century and h...of antler through a long-standing collaboration wi...
(Date:11/26/2009)...AMBRIDGE, Mass. (November 26, 2009) Whitehead res...en for human cells to pinpoint specific genes and ...er in Science . , In most human cell cultures g... the father and one from the mother. Gene inactiva...when one copy is inactivated, the second copy usua...
Breaking Biology News(10 mins):New VeriLook 4.0 for Biometric Facial Recognition and MegaMatcher 3.1 for Multi-biometric Applications Are Now Available 2New VeriLook 4.0 for Biometric Facial Recognition and MegaMatcher 3.1 for Multi-biometric Applications Are Now Available 3Tough yet stiff deer antler is materials scientist's dream 2Knockouts in human cells point to pathogenic targets 2State to Invest 2411 1 Million in Expansion of Doylestown Hospital 48532 1State to Invest 2411 1 Million in Expansion of Doylestown Hospital 48532 2Genetic Links to Rare Liver Disease Found 48528 1Genetic Links to Rare Liver Disease Found 48528 2Genetic Links to Rare Liver Disease Found 48528 3FDA Panel OKs Newer Antipsychotics for Children 48524 1FDA Panel OKs Newer Antipsychotics for Children 48524 2FDA Panel OKs Newer Antipsychotics for Children 48524 3FDA Panel OKs Newer Antipsychotics for Children 48524 4
...eir mates based on fancy feathers. Female mammals,...heir noses to the right mate. That,s one conclusio...vard researcher Katherine McAuliffe, whose review ... the March 2009 issue of The Quarterly Review of ... mate choice and its evolutionary consequences are...
...st edition of an essential reference volume in o... of clinical medicine. Covering novel viruses, pat... prevention, Clinical Virology informs scientist...cally relevant aspects of this rapidly evolving fi...ynamic areas of clinical medicine. Challenges rel...
...2009While the Bernard Madoff Ponzi scheme led to t...efactor for life science research, many bioindustr... minor consequence in the larger economic picture,... (GEN). They look at the Madoff factor as represe...ironment that has been rocked by declining stock p...
Other Biology News:Female mammals follow their noses to the right mates 2New edition available for essential virology reference 2GEN reports on Madoff scandal's impact on the life sciences 2
...active, real-time sample temperature monitoring. ,...ds first, fully modular SpeedVac System. The three...an integrated unit or separated to maximize valuab...ve sample temperature monitoring. Automatic contro...
...r vacuum concentrator/centrifugal evaporator syst...biology and biochemistry for rapid and safe concen... be expanded with pumps, different of cold traps a...loss by transfer), ensuring solvent recovery and s...
...ncentrator for efficient drying of small volumes o...tegrated system combines the SpeedVac™ Conce...compact design, automatic pump and rotor control, ...time), makes the DNA120 indispensable in the labor...
...r small quantities of solvents with DNA and other ...centrifugal evaporator systems respond to specific...y for rapid and safe concentration of heat-labile ..., different of cold traps and a wide selection of ...
Biology Products: